Measuring the Success of Keep Well in Lanarkshire

1
Measuring the Success ofKeep Well in Lanarkshire

• Kerri Todd
• Assistant Health Promotion Manager
• NHS Lanarkshire

2
Presentation Outline

• Overview of Keep Well in Lanarkshire
• Model screening data
• Clinical Data
• Main findings for CVD risk factors
• Diagnoses medications
• Acknowledgements

Measuring the success of KW in Lanarkshire 13th
November 2009
3
Keep Well in Lanarkshire Overview

• Inequalities targeted CVD health checks for 45-64
  year olds
• Wave 1 Oct 2006 (3 localities)
• Wave 1 extension - Feb 2009 (1 locality)
• Wave 4 June 2009 (2 localities and
• 3 targeted populations)
• Total screened 16, 401 (30 Sept 2009)

Measuring the success of KW in Lanarkshire 13th
November 2009
4
Clinical Data

• Paired clinical data for 26/29 wave 1 practices
  for patients screened to 30 June 2009
• 9,568 patients
• Males 4,544 (47)
• Females 5,024 (53)
• 58 of patients from SIMD quintiles 4 5

Measuring the success of KW in Lanarkshire 13th
November 2009
5
Blood Pressure

• Blood pressure (n4123)
• 668 patients with raised BP (gt150/90)
• Average decrease in BP
  
• Systolic males 13mmHg females 15mmHg
• Diastolic males 9mmHg females 9mmHg

Measuring the success of KW in Lanarkshire 13th
November 2009
6
Cholesterol

• Cholesterol (n2191)
• - 1223 patients with raised cholesterol
  (gt5.0mmol)
• Average decrease in cholesterol
• Males 0.5mmol
• Females 0.6mmol

Measuring the success of KW in Lanarkshire 13th
November 2009
7
Smoking and Obesity

• 2809 patients recorded as smokers
• 2284 given smoking advice
• From total KW population, 804 referred to Stop
  Smoking Service (to 30 Sept 09)
• 2933 patients with BMI gt30
• From total KW population, 2644 referred to
  Counterweight (to 30 Sept 09)

Measuring the success of KW in Lanarkshire 13th
November 2009
8
Diagnoses

• Hypertension - 523
• Diabetes - 171
• Cardiovascular Disease 313
• COPD or asthma - 197

Measuring the success of KW in Lanarkshire 13th
November 2009
9
Therapeutics

• 1023 patients started on/changes to lipid
  lowering drugs
• 583 patients started on/changes to calcium
  channel blocker
• 450 patients started on/changes to ACE inhibitor
• 226 patients started on/changes to AIIs
• 477 patients started on/changes to beta blocker
• 371 patients started on/changes to diuretics
• 429 patients started on/changes to antiplatelets
• 60 patients started on/changes to anticoagulents
• 91 patients started on oral diabetic medication
• 11 patients started on insulin

Measuring the success of KW in Lanarkshire 13th
November 2009
10
Conclusion

• Keep Well in Lanarkshire is demonstrating a
  positive impact on its target population
• good reach in deprived communities
• range of CVD risk factors identified and treated
• good attendance at screening by males

Measuring the success of KW in Lanarkshire 13th
November 2009
11
Acknowledgements

• The Lanarkshire Keep Well Project Board
• In particular,
• Gabe Docherty, Project Lead, NHSL
• Jill Madden, KW Project Manager, NHSL
• Philip McMenemy, KW Clinical Lead, NHSL
• Stuart Davis, KW Data Analyst, NHSL
• Scottish Government and NHS Health Scotland for
  funding and support

Measuring the success of KW in Lanarkshire 13th
November 2009